Controversies in preservation of ovary function and fertility in patients with breast cancer

Breast Cancer Research and Treatment

Volumn 108, Issue 1, 2008, Pages 1-7

  Gerber, Bernd ^a   Dieterich, Max ^a   Müller, Heiner ^a   Reimer, Toralf ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Amenorrhea; Breast cancer; Cryopreservation; Fertility; Ovary function; Ovary protection

Indexed keywords

BLEOMYCIN; BUSULFAN; CAPECITABINE; CHLORAMPHENICOL; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FLUOROURACIL; GONADORELIN AGONIST; GONADOTROPIN; GOSERELIN; IRINOTECAN; LETROZOLE; METHOTREXATE; OXALIPLATIN; PREDNISOLONE; TAMOXIFEN; VINBLASTINE; VINCRISTINE;

AMENORRHEA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; CRYOPRESERVATION; DISEASE FREE SURVIVAL; DYSPAREUNIA; FEMALE FERTILITY; FERTILIZATION IN VITRO; HORMONAL THERAPY; HOT FLUSH; HUMAN; LIBIDO DISORDER; MENTAL DISEASE; NONHUMAN; OSTEOPOROSIS; OVARY DISEASE; OVARY FUNCTION; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER; STEM CELL TRANSPLANTATION; SWEAT; VAGINA ATROPHY;

AMENORRHEA; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CRYOPRESERVATION; FEMALE; FERTILITY; HUMANS; INFERTILITY, FEMALE; OVARY; PREGNANCY;

EID: 43049139938     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9572-1     Document Type: Review

References (51)

1. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917-2931
2. Pritchard KI (2002) Adjuvant therapy for premenopausal women with breast cancer: is it time for another paradigm shift? J Clin Oncol 20:4611-4614
3. Fornier MN, Modi S, Panageas KS, Norton L, Hudis C (2005) Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 104:1575-1579
4. De Haes H, Olschewski M, Kaufmann M, Schumacher M, Jonat W, Sauerbrei W (2003) Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the zoladex early breast cancer research association trialists group. J Clin Oncol 21:4510-4516
5. Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE (2003) Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21:4184-4193
6. Ghidoni R, Boccardi M, Benussi L, Testa C, Villa A, Pievani M, Gigola L, Sabattoli F, Barbiero L, Frisoni GB, Binetti G (2006) Effects of estrogens on cognition and brain morphology: involvement of the cerebellum. Maturitas 54:222-228
7. Nystedt M, Berglund G, Bolund C, Fornander T, Rutqvist LE (2003) Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study. J Clin Oncol 21:1836-1844
8. Tchen N, Juffs HG, Downie FP, Yi QL, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D, Tweedale ME, Tannock IF (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175-4183
9. EBCTCG (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687-1717
10. Duffy CM, Allen SM, Clark MA (2005) Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 23:766-773
11. Holmberg L, Anderson H (2004) HABITS (hormonal replacement therapy after breast cancer-is it safe?), a randomised comparison: trial stopped. Lancet 363:453-455
12. Ataya K, Rao LV, Lawrence E, Kimmel R (1995) Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 52:365-372
13. Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, Robison LL, Sklar CA (2006) Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 91:1723-1728
14. Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, Mulder J, Green D, Nicholson HS, Yasui Y, Robison LL (2006) Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 98:890-896
15. Petrek JA, Naughton MJ, Case LD, Paskett ED, Naftalis EZ, Singletary SE, Sukumvanich P (2006) Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 24:1045-1051
16. Muller H (1990) Effects of adjuvant chemotherapy of breast cancer on gonadal function. Zentralbl Gynakol 112:795-801
17. Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346:1609-1615
18. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616-1622
19. Cuzick J (2006) The impact of LHRH agonists on breast cancer recurrence and mortality: an overview of the randomized trials. Breast Cancer Res Treat 100(Suppl. 1):S10
20. EBCTCG (2000) Ovarian ablation for early breast cancer. Cochrane Database Syst Rev: CD000485
21. Gnant M, Greil R, Kubista E, Menzel C, Schippinger W, Seifert B, Haider K, Jakesz R (2006) The impact of treatment-induced amenorrhea on survival of premenopausal patients with endocrine-responsive breast cancer: 10-year result of ABCSG-05 (CMF vs. goserelin + tamoxifen). Breast Cancer Res Treat 100(Suppl 1):S10
22. Love RR, Duc NB, Allred DC, Binh NC, Dinh NV, Kha NN, Thuan TV, Mohsin SK, Roanh lD, Khang HX, Tran TL, Quy TT, Thuy NV, The PN, Cau TT, Tung ND, Huong DT, Quang lM, Hien NN, Thuong L, Shen TZ, Xin Y, Zhang Q, Havighurst TC, Yang YF, Hillner BE, DeMets DL (2002) Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer. J Clin Oncol 20:2559-2566
23. Klijn JG, Blamey RW, Boccardo F, Tominaga T, Duchateau L, Sylvester R (2001) Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. J Clin Oncol 19:343-353
24. Beatson GT (1896) On the treatment of inoperable cases of carcinoma of the mamma. Suggestions for a new method of treatment with illustrative cases. Lancet 2:104-107
25. Davis AL, Klitus M, Mintzer DM (2005) Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes. Clin Breast Cancer 6:421-424
26. Colleoni M, Gelber S, Goldhirsch A, Aebi S, Castiglione-Gertsch M, Price KN, Coates AS, Gelber RD (2006) Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93. J Clin Oncol 24:1332-1341
27. Braverman AS, Sawhney H, Tendler A, Patel N, Rao CS (2002) Pre-menopausal serum estradiol levels may persist after chemotherapy-induced amenorrhea in breast cancer. Proc Am Soc Clin Oncol 21:42a (abstr 164)
28. Baum M, Houghton J, Odling-Smee W, Rutqvist LE, Fornander T, Nordenskjold B, Nicolucci A, Mark RJ (2001) Adjuvant treatment of premenopausal breast cancer with zoladex and tamoxifen: results from randomized trials by the Cancer Research Campaign (CRC) Breast Cancer Trials Group, The Stockholm Breast Cancer Study Group, The South East Sweden Breast Cancer Group and Gruppo Interdisciplinare Valutazione Intervention Oncologica (GIVIO). Breast 10(Suppl 1):P64
29. Castiglione-Gertsch M, O'Neill A, Price KN, Goldhirsch A, Coates AS, Colleoni M, Nasi ML, Bonetti M, Gelber RD (2003) Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. J Natl Cancer Inst 95:1833-1846
30. Davidson NE, O'Neill A, Vukov A, Osborne CK, Martino S, White D, Abeloff MD (2003) Effect of chemohormonal therapy in premenopausal node positive, receptor positive breast cancer: an Eastern Cooperative Oncology Group Phase III Intergroup trial (E5188, Int-0101). J Clin Oncol (Proc Am Soc Clin Oncol) 21:15 (abstr)
31. Walshe JM, Denduluri N, Swain SM (2006) Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24:5769-5779
32. Vanhuyse M, Fournier C, Bonneterre J (2005) Chemotherapy-induced amenorrhea: influence on disease-free survival and overall survival in receptor-positive premenopausal early breast cancer patients. Ann Oncol 16:1283-1288
33. Jonat W, Kaufmann M, Sauerbrei W, Blamey R, Cuzick J, Namer M, Fogelman I, de Haes JC, de Matteis A, Stewart A, Eiermann W, Szakolczai I, Palmer M, Schumacher M, Geberth M, Lisboa B (2002) Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. J Clin Oncol 20:4628-4635
34. Borde F, Chapelle-Marcilac IFP, Hery M, Bonneterre J, Kerbrat P (2003) Role of chemo-induced amenorrhea in premenopausale, node-positive, operable breast cancer patients: 9-year follow-up results of French Adjuvant Study Group (FASG) data base. Breast Cancer Res Treat 82(Suppl 1):30
35. http://www.bqs-qualitaetsreport.de/. BQS. (2007)
36. Del Mastro L, Venturini M (2006) Fertility preservation strategies for breast cancer patients. J Clin Oncol 24:4220-4221
37. Ives A, Saunders C, Bulsara M, Semmens J (2006) Pregnancy after breast cancer: population based study. BMJ 334:166-167
38. Blakely LJ, Buzdar AU, Lozada JA, Shullaih SA, Hoy E, Smith TL, Hortobagyi GN (2004) Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 100:465-469
39. Mueller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR (2003) Childbearing and survival after breast carcinoma in young women. Cancer 98:1131-1140
40. Velentgas P, Daling JR, Malone KE, Weiss NS, Williams MA, Self SG, Mueller BA (1999) Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 85:2424-2432
41. Goldhirsch A, Glick JH, Gelber RD, Coates A, Senn HJ (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16:1569-1583
42. Blumenfeld Z (2002) Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers. Mol Cell Endocrinol 187:93-105
43. Franke HR, Smit WM, Vermes I (2005) Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy. Gynecol Endocrinol 20:274-278
44. Fox K, Scialla J, Moore H (2003) Preventing chemotherapy-related amenorrhea using leuprolide during adjuvant chemotherapy for early-stage breast cancer. Proc Am Soc Clin Oncol 22:13
45. Recchia F, Saggio G, Amiconi G, Di Blasio A, Cesta A, Candeloro G, Rea S (2006) Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 106:514-523
46. Del Mastro L, Catzeddu T, Boni L, Bell C, Sertoli MR, Bighin C, Clavarezza M, Testa D, Venturini M (2006) Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol 17:74-78
47. Urruticoechea A, Walsh G, Rigg A, Dowsett M, Smith IE (2004) Ovarian function protection with goserelin during adjuvant chemotherapy in pre-menopausal women with early breast cancer. Breast Cancer Res Treat 88(Suppl 1):S229
48. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z (2005) Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23:4347-4353
49. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H (2006) Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 91:3885-3890
50. Sonmezer M, Oktay K (2006) Fertility preservation in young women undergoing breast cancer therapy. Oncologist 11:422-434
51. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364:1405-1410